Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

How To Handle Off-Label Promotion: A Guide From PhRMA And BIO

Aug 05 2016

• By Derrick Gingery and Donna Young

business

Related Content

PhRMA/BIO Devise 'Principles' To End Off-Label Limbo

Aug 05 2016

Social Media Marketing: FDA’s Old-Time Approach May Turn Industry Away

Jun 23 2014

US FDA Sets Goal For Biosimilar, Drug Promotion Guidances

Jan 26 2016

Cost Effectiveness Debate Now Features The Body Bag Argument

May 25 2016

Sandoz's Multi-Switch Biosimilar Trials: A View To Interchangeability?

Jul 22 2016

Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact

Mar 21 2016

Clinton Vs. Trump: Three Scenarios For Biopharma

Jul 25 2016

Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes

Jul 27 2016

Related Companies

Express Scripts Holding Company

CVS Health Corp.

Additional Topics

United States Advertising, Marketing & Sales Policy Regulation Commercial BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window